• Join LYTONE 加入利統
  • Online Shop 線上購買
ConsultingConsulting

INVESTOR

Company Organization Financial Information Corporate Governance Shareholder Services

Corporate Governance

Governing Board of Directors

1.Terms: July 1, 2021 to June 30, 2024
2. Board Members:

Title Board Director
Name William T.H. Chang
Key Current Positions
  • Chairman and General Mamager
Professional Background
  • Ph.D., Industr. Microbiology, Texas Tech University;
  • Deputy Executive Officer, Development Center for Biotechnology
Title Board Director
Name Thomas Shen, Apex Biotech Corp.
Key Current Positions
  • Board Chairman and General Manager, Apex
Professional Background
  • Ph.D., Biochemistry, Univ. of Massachusetts
  • Professor, Molecular Biology, National Tsing Hua Univ.
Title Board Director
Name J.M. Sung
Key Current Positions
  • Chairman, Green Dezyme Biotech
Professional Background
  • Ph.D., Texas Tech
Title Board Director
Name Heidi Huang
Key Current Positions
  • Independent Director, Chi Hua Fitness Co., Ltd.
Professional Background
  • MBA, Oklahoma City Univ.
  • General Manager, Asia & Pacific Marketing, Motorola
  • Chief Marketing Director, Johnson & Johnson Medical
Title Independent Director
Name Dr. Leah Lo
Key Current Positions
  • Independent Director, Formosa Pharmaceuticals
Professional Background
  • Ph.D., Botanical Pedology, Univ. of Massachusetts
  • General Manager, Oriental Pharma Co., Ltd.
Title Independent Director
Name Shi-Yen Shiau
Key Current Positions
  • Life-time National Endowed Chair Professor
  • Tenured Distinguished Professor, National Taiwan Ocean University
Professional Background
  • Ph.D., Food Nutrition, Texas Tech
Title Independent Director
Name Dale Chen
Key Current Positions
  • Director, Evershine CPAs Firm
Professional Background
  • Ph.D., Business Administration, Victoria Univ., Switzerland

Functional Committee

The Audit Committee

Audit Committee First Term
Term: July 1, 2021 to June 30, 2024
Audit Committee Members:

Name Dr. Leah Lo
Key Current Positions
  • Independent Director, Formosa Pharmaceuticals
Professional Background
  • Ph.D., Botanical Pedology, Univ. of Massachusetts; General Manager, Oriental Pharma Co., Ltd.
Name Shi-Yen Shiau
Key Current Positions
  • Life-time National Endowed Chair Professor; Tenured Distinguished Professor, National Taiwan Ocean University
Professional Background
  • Ph.D., Food Nutrition, Texas Tech
Name Dale Chen
Key Current Positions
  • Director, Evershine CPAs Firm
Professional Background
  • Ph.D., Business Administration, Victoria Univ., Switzerland

Remuneration Committee

First Term
Term: July 1, 2021 to June 30, 2024
Members

Name Dr. Leah Lo
Key Current Positions
  • Independent Director, Formosa Pharmaceuticals
Professional Background
  • Ph.D., Botanical Pedology, Univ. of Massachusetts; General Manager, Oriental Pharma Co., Ltd.
Name Shi-Yen Shiau
Key Current Positions
  • Life-time National Endowed Chair Professor; Tenured Distinguished Professor, National Taiwan Ocean University
Professional Background
  • Ph.D., Food Nutrition, Texas Tech
Name Dale Chen
Key Current Positions
  • Director, Evershine CPAs Firm
Professional Background
  • Ph.D., Business Administration, Victoria Univ., Switzerland

Rules & Regulations

SubjectsRenewed DateFile Download
公司章程2023-04-27download
股東會議事規則2023-04-27download
董事會議事規則2023-04-27download
審計委員會組織規程2023-04-27download
薪資報酬委員會組織規程2023-04-27download
公司治理實務守則2023-04-27download
永續發展實務守則2023-04-27download
道德行為準則2023-04-27download
誠信經營守則2023-04-27download
防範內線交易管理辦法2023-04-27download

Internal Audit

Organiation & Operation of Internal Audit:

1. Objectives of Internal Audit:

To assist the Board and Managers in overseeing the implementation of its internal audit system to evaluate their efficiency and provide improvement suggestions.

2. Organization of Internal Audit:

Directly under the Board of Directors. The employment and/or separation of the Chief Auditor must be approved by the Audit Committee and passed the Board. The size of the Auditor office is based on Company's business status.

3. Operation of Internal Audit:

Its scope includes Company's business, administration, all divisions as well as its subsidiaries. The internal audit office is supposed to prepare, by year-end, an annual audit plan for the upcoming year, to be passed by the Board.

It is supposed to carry out the annual audit plan to evluate the implementation of Company's internal control system and to preare audit reports after evaluation.

Should there be any shortcoming, the audit office is required to prepare regular track reports until the relevant divisions have taken appropriate remedies.

Internal auditors are required to send the audit reports and rmedy reports to Independent Directors.

The Chief Audit Officer is required to be present at the meetings of the Board and the Audit Committee to report Company's audit business.

The Audit Office is supposed to urge each division/office to conduct self-evaluation at least once per year; to review the self-evaluation and to report the outcome and any internal control shortcoming/remedy as the major bases of company's effectiveness over its internal control system as well as the submission of Company's Internal Control System Statement to the authorities.

BACK TO TOP